Effectiveness of Ramadan diurnal intermittent fasting and concurrent training in the management of obesity: is the combination worth the weight?
Concurrent exercise training
HIIT
Intermittent fasting
Obesity
Time restricted eating
Journal
Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
07
05
2022
revised:
27
11
2022
accepted:
07
12
2022
pubmed:
30
1
2023
medline:
25
2
2023
entrez:
29
1
2023
Statut:
ppublish
Résumé
We investigated, in men with obesity, the efficacy of the combination of two strategies (Ramadan diurnal intermittent fasting 'RDIF' strategy vs RDIF plus concurrent training program 'RDIF-CT' strategy) known for their positive impact on body composition and then we explored the possible impact on metabolic and inflammatory biomarkers. Twenty obese men, age: 31.8 ± 7.05 years, BMI: 33.1 ± 4.2 kg m Our results suggest that a combination of RDIF and CT induces greater changes in body composition, lipid profile, inflammation and liver biomarkers compared to RDIF strategy alone. PACTR202203475387226.
Sections du résumé
BACKGROUND AND AIMS
We investigated, in men with obesity, the efficacy of the combination of two strategies (Ramadan diurnal intermittent fasting 'RDIF' strategy vs RDIF plus concurrent training program 'RDIF-CT' strategy) known for their positive impact on body composition and then we explored the possible impact on metabolic and inflammatory biomarkers.
METHODS AND RESULTS
Twenty obese men, age: 31.8 ± 7.05 years, BMI: 33.1 ± 4.2 kg m
CONCLUSIONS
Our results suggest that a combination of RDIF and CT induces greater changes in body composition, lipid profile, inflammation and liver biomarkers compared to RDIF strategy alone.
CLINICAL TRIAL REGISTER
PACTR202203475387226.
Identifiants
pubmed: 36710112
pii: S0939-4753(22)00491-4
doi: 10.1016/j.numecd.2022.12.004
pii:
doi:
Substances chimiques
Blood Glucose
0
Lipids
0
Biomarkers
0
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
659-666Informations de copyright
Copyright © 2022. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest.